Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Testosterone enanthate expiration?Patent expiration eu dabrafenib?Abbvie humira patent cliff navigation success?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for Omidria
Omidria (phenylephrine and ketorolac injection) received FDA approval on April 10, 2014. [1]
Omidria is used to help improve outcomes in cataract surgery—specifically to reduce the incidence of postoperative ocular pain and constriction (pupillary constriction) during and after cataract procedures. [1]
The FDA’s approval date is listed in the drug’s FDA review/approval history on the FDA label information page for Omidria. [1]
Other Questions About Omidria :